Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ebtesam N. Alsultan"'
Autor:
Mai M. Al-Oqail, Ebtesam S. Al-Sheddi, Nida N. Farshori, Shaza M. Al-Massarani, Ebtesam N. Alsultan, Javed Ahmad, Abdulaziz A. Al-Khedhairy, Maqsood A. Siddiqui
Publikováno v:
Journal of King Saud University: Science, Vol 36, Iss 9, Pp 103390- (2024)
Background: Hepatocellular carcinoma is the most prevalent type of primary liver cancer and remains the foremost cause of cancer-related deaths globally. Dill (Anethum graveolens) seeds, rich in phytoconstituents, is renowned for their pharmacologica
Externí odkaz:
https://doaj.org/article/24253d7630914381b08f34351ab10baf
Autor:
Ahlam M. Alhusaini, Hanan K. Alghibiwi, Wedad S. Sarawi, Juman S. Alsaab, Samiyah M. Alshehri, Qamraa H. Alqahtani, Aliah R. Alshanwani, Ebtesam A. Aljassas, Ebtesam N. Alsultan, Iman H. Hasan
Publikováno v:
Dose-Response, Vol 22 (2024)
Isoproterenol (ISO), a chemically synthesized catecholamine, belongs to β-adrenoceptor agonist used to treat bradycardia. The β-adrenergic agonist is an essential regulator of myocardial metabolism and contractility; however, excessive exposure to
Externí odkaz:
https://doaj.org/article/f7023449ef8a4ce189272c484977cad6
Autor:
Ahlam M. Alhusaini, Samiyah M. Alshehri, Wedad S. Sarawi, Hanan K. Alghibiwi, Sumayya A. Alturaif, Reema A. Al khbiah, Shog M. Alali, Shaikha M. Alsaif, Ebtesam N. Alsultan, Iman H. Hasan
Publikováno v:
Saudi Pharmaceutical Journal, Vol 32, Iss 1, Pp 101907- (2024)
Background and Objective: Isoproterenol (ISO) is a non-selective β-adrenergic receptor agonist. It can be used to treat bradycardia and cardiogenic shock. Despite its usefulness, the overstimulation of β-receptors by ISO can cause “cardiorenal sy
Externí odkaz:
https://doaj.org/article/46819b5cdc584f77bc74045d73fa1825